US 8449884
Clotting factor-fc chimeric proteins to treat hemophilia
granted A61KA61K2039/60A61K38/36
Quick answer
US patent 8449884 (Clotting factor-fc chimeric proteins to treat hemophilia) held by Syntonix Pharmaceuticals, Inc. expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Syntonix Pharmaceuticals, Inc.
- Grant date
- Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/60, A61K38/36, A61K38/4846, A61K45/06